Article Text

Download PDFPDF
Paraneoplastic Lambert-Eaton myasthenic syndrome: a diagnostic challenge
  1. Luísa Viveiros,
  2. Sara Raquel Martins,
  3. Sara Xavier Pires and
  4. João Neves
  1. Department of Internal Medicine, Centro Hospitalar Universitário do Porto, EPE, Porto, Portugal
  1. Correspondence to Dr Luísa Viveiros; analuisaviveiros{at}gmail.com

Abstract

Lambert-Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disorder. Underlying small cell lung cancer is found in more than half of patients. Proximal muscle weakness, autonomic features and areflexia are typical manifestations. However, LEMS is often misdiagnosed. We report a rare case of paraneoplastic LEMS, identified amid admission due to a different diagnosis. Our patient was initially admitted due to aspiration pneumonia. Further investigation revealed clinical and electrophysiological manifestations of LEMS. High clinical suspicion and early diagnostic workup were paramount in the patient outcome. Nevertheless, paraneoplastic aetiology was difficult to confirm and revealed itself a difficult challenge. Clinical awareness is crucial to diagnose LEMS and urge cancer screening and early treatment.

  • Neuromuscular disease
  • Lung cancer (oncology)

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors LV was involved in drafting, writing, literature review and final approval. SRM and SXP were involved in literature review and final approval. JN was involved in editing and final approval.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.